https://stock.noler.com/us/stock/talis-biomedical-corporation https://stock.noler.com/us/stock/talis-biomedical-corporation/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/talis-biomedical-corporation/accounts-payable https://stock.noler.com/us/stock/talis-biomedical-corporation/accrued-liabilities-current https://stock.noler.com/us/stock/talis-biomedical-corporation/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/talis-biomedical-corporation/accrued-professional-fees-current https://stock.noler.com/us/stock/talis-biomedical-corporation/accumulated-depreciation https://stock.noler.com/us/stock/talis-biomedical-corporation/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/talis-biomedical-corporation/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/talis-biomedical-corporation/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/talis-biomedical-corporation/asset-impairment-charges https://stock.noler.com/us/stock/talis-biomedical-corporation/assets-fair-value-disclosure https://stock.noler.com/us/stock/talis-biomedical-corporation/basic-shares https://stock.noler.com/us/stock/talis-biomedical-corporation/capital-expenditures https://stock.noler.com/us/stock/talis-biomedical-corporation/cash-and-equivalents https://stock.noler.com/us/stock/talis-biomedical-corporation/cash-and-restricted-cash https://stock.noler.com/us/stock/talis-biomedical-corporation/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/talis-biomedical-corporation/cash-flow-breakdown https://stock.noler.com/us/stock/talis-biomedical-corporation/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/talis-biomedical-corporation/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/talis-biomedical-corporation/common-stock-value https://stock.noler.com/us/stock/talis-biomedical-corporation/construction-in-progress-gross https://stock.noler.com/us/stock/talis-biomedical-corporation/contract-with-customer-refund-liability https://stock.noler.com/us/stock/talis-biomedical-corporation/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/talis-biomedical-corporation/cost-of-revenue https://stock.noler.com/us/stock/talis-biomedical-corporation/costs-and-expenses https://stock.noler.com/us/stock/talis-biomedical-corporation/cover-page-shares-outstanding https://stock.noler.com/us/stock/talis-biomedical-corporation/current-assets https://stock.noler.com/us/stock/talis-biomedical-corporation/current-liabilities https://stock.noler.com/us/stock/talis-biomedical-corporation/deferred-income-tax-liabilities https://stock.noler.com/us/stock/talis-biomedical-corporation/deferred-tax-assets-gross https://stock.noler.com/us/stock/talis-biomedical-corporation/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/talis-biomedical-corporation/deferred-tax-assets-inventory https://stock.noler.com/us/stock/talis-biomedical-corporation/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/talis-biomedical-corporation/deferred-tax-assets-net https://stock.noler.com/us/stock/talis-biomedical-corporation/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/talis-biomedical-corporation/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/talis-biomedical-corporation/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/talis-biomedical-corporation/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/talis-biomedical-corporation/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/talis-biomedical-corporation/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/talis-biomedical-corporation/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/talis-biomedical-corporation/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/talis-biomedical-corporation/depreciation https://stock.noler.com/us/stock/talis-biomedical-corporation/depreciation-and-amortization-expense https://stock.noler.com/us/stock/talis-biomedical-corporation/diluted-shares https://stock.noler.com/us/stock/talis-biomedical-corporation/dividends-payable-current-and-noncurrent https://stock.noler.com/us/stock/talis-biomedical-corporation/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/talis-biomedical-corporation/employee-related-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/talis-biomedical-corporation/eps https://stock.noler.com/us/stock/talis-biomedical-corporation/eps-basic https://stock.noler.com/us/stock/talis-biomedical-corporation/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/talis-biomedical-corporation/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/talis-biomedical-corporation/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/talis-biomedical-corporation/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/talis-biomedical-corporation/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-into-level https://stock.noler.com/us/stock/talis-biomedical-corporation/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-out-of-level https://stock.noler.com/us/stock/talis-biomedical-corporation/financing-cash-flow https://stock.noler.com/us/stock/talis-biomedical-corporation/form-d-other https://stock.noler.com/us/stock/talis-biomedical-corporation/grants-receivable-current https://stock.noler.com/us/stock/talis-biomedical-corporation/gross-profit https://stock.noler.com/us/stock/talis-biomedical-corporation/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/talis-biomedical-corporation/income-tax https://stock.noler.com/us/stock/talis-biomedical-corporation/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/talis-biomedical-corporation/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/talis-biomedical-corporation/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/talis-biomedical-corporation/increase-decrease-in-inventories https://stock.noler.com/us/stock/talis-biomedical-corporation/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/talis-biomedical-corporation/increase-decrease-in-other-noncurrent-assets-and-liabilities-net https://stock.noler.com/us/stock/talis-biomedical-corporation/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/talis-biomedical-corporation/insider-transactions-preferred https://stock.noler.com/us/stock/talis-biomedical-corporation/insider-transactions-stock-options https://stock.noler.com/us/stock/talis-biomedical-corporation/insider-transactions-stock-units https://stock.noler.com/us/stock/talis-biomedical-corporation/inventory https://stock.noler.com/us/stock/talis-biomedical-corporation/inventory-valuation-reserves https://stock.noler.com/us/stock/talis-biomedical-corporation/investing-cash-flow https://stock.noler.com/us/stock/talis-biomedical-corporation/lease-cost https://stock.noler.com/us/stock/talis-biomedical-corporation/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/talis-biomedical-corporation/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/talis-biomedical-corporation/level-3-asset-transfers-into-level https://stock.noler.com/us/stock/talis-biomedical-corporation/level-3-asset-transfers-out-of-level https://stock.noler.com/us/stock/talis-biomedical-corporation/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/talis-biomedical-corporation/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/talis-biomedical-corporation/net-change-in-cash https://stock.noler.com/us/stock/talis-biomedical-corporation/net-income https://stock.noler.com/us/stock/talis-biomedical-corporation/noncash-or-part-noncash-acquisition-value-of-assets-acquired https://stock.noler.com/us/stock/talis-biomedical-corporation/number-of-operating-segments https://stock.noler.com/us/stock/talis-biomedical-corporation/number-of-reportable-segments https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-cash-flow https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-expenses https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-income https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-lease-assets https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-lease-cost https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-lease-liability https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-lease-liability-current https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-lease-payments https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-lease-payments-due https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/talis-biomedical-corporation/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/talis-biomedical-corporation/other-current-liabilities https://stock.noler.com/us/stock/talis-biomedical-corporation/other-noncurrent-assets https://stock.noler.com/us/stock/talis-biomedical-corporation/other-nonoperating-expense https://stock.noler.com/us/stock/talis-biomedical-corporation/other-nonoperating-income https://stock.noler.com/us/stock/talis-biomedical-corporation/other-nonoperating-income-expense https://stock.noler.com/us/stock/talis-biomedical-corporation/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/talis-biomedical-corporation/payments-for-repurchase-of-initial-public-offering https://stock.noler.com/us/stock/talis-biomedical-corporation/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/talis-biomedical-corporation/preferred-shares-facts https://stock.noler.com/us/stock/talis-biomedical-corporation/preferred-stock-no-par-value https://stock.noler.com/us/stock/talis-biomedical-corporation/preferred-stock-shares-authorized https://stock.noler.com/us/stock/talis-biomedical-corporation/preferred-stock-shares-issued https://stock.noler.com/us/stock/talis-biomedical-corporation/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/talis-biomedical-corporation/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/talis-biomedical-corporation/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/talis-biomedical-corporation/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/talis-biomedical-corporation/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/talis-biomedical-corporation/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/talis-biomedical-corporation/proceeds-from-stock-issued https://stock.noler.com/us/stock/talis-biomedical-corporation/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/talis-biomedical-corporation/proceeds-from-stock-plans https://stock.noler.com/us/stock/talis-biomedical-corporation/profit-loss https://stock.noler.com/us/stock/talis-biomedical-corporation/property-plant-and-equipment-gross https://stock.noler.com/us/stock/talis-biomedical-corporation/property-plant-equipment https://stock.noler.com/us/stock/talis-biomedical-corporation/public-float https://stock.noler.com/us/stock/talis-biomedical-corporation/purchase-obligation https://stock.noler.com/us/stock/talis-biomedical-corporation/research-and-development https://stock.noler.com/us/stock/talis-biomedical-corporation/restricted-cash https://stock.noler.com/us/stock/talis-biomedical-corporation/restricted-cash-current https://stock.noler.com/us/stock/talis-biomedical-corporation/restricted-cash-equivalents-noncurrent https://stock.noler.com/us/stock/talis-biomedical-corporation/restricted-cash-noncurrent https://stock.noler.com/us/stock/talis-biomedical-corporation/retained-earnings https://stock.noler.com/us/stock/talis-biomedical-corporation/revenue https://stock.noler.com/us/stock/talis-biomedical-corporation/revenue-not-from-contract-with-customer https://stock.noler.com/us/stock/talis-biomedical-corporation/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/talis-biomedical-corporation/severance-costs https://stock.noler.com/us/stock/talis-biomedical-corporation/sga-expense https://stock.noler.com/us/stock/talis-biomedical-corporation/shareholders-equity https://stock.noler.com/us/stock/talis-biomedical-corporation/shares-authorized https://stock.noler.com/us/stock/talis-biomedical-corporation/shares-issued https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-award-plan-modification-incremental-compensation-cost https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-based-compensation https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-issued-new-shares-sold https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-issued-shares-issued-shares-employee-benefit-plan https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-issued-shares-issued-value-employee-benefit-plan https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-exercisable-number https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-expirations-in-period https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-outstanding-number https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/talis-biomedical-corporation/stock-split-ratio https://stock.noler.com/us/stock/talis-biomedical-corporation/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/talis-biomedical-corporation/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/talis-biomedical-corporation/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/talis-biomedical-corporation/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/talis-biomedical-corporation/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/talis-biomedical-corporation/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/talis-biomedical-corporation/temporary-equity-shares-authorized https://stock.noler.com/us/stock/talis-biomedical-corporation/temporary-equity-shares-issued https://stock.noler.com/us/stock/talis-biomedical-corporation/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/talis-biomedical-corporation/total-assets https://stock.noler.com/us/stock/talis-biomedical-corporation/total-liabilities https://stock.noler.com/us/stock/talis-biomedical-corporation/total-liabilities-and-equity https://stock.noler.com/us/stock/talis-biomedical-corporation/unrecognized-tax-benefits https://stock.noler.com/us/stock/talis-biomedical-corporation/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/talis-biomedical-corporation/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/talis-biomedical-corporation/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/talis-biomedical-corporation/variable-lease-cost https://stock.noler.com/us/stock/talis-biomedical-corporation/weighted-average-number-of-share-outstanding-basic-and-diluted